For example, oncogenic PVT1 are overexpressed across multiple cancer types because of amplification [16]; TERT presented increased expression across multiple cancer types because of recurrent somatic mutations in the promoter [49]; MEG3 are underexpressed in tumors mainly due to promoter silencing by hypermethylation [50]. This evidence concerns the gene MEG3 and cancer.